| Vero cell upstream bioprocess development for the production of viral vectors and vaccines S Kiesslich, AA Kamen Biotechnology advances 44, 107608, 2020 | 129 | 2020 |
| A Review of Process-Design Challenges for Industrial Fermentation of Butanol from Crude Glycerol by Non-Biphasic Clostridium pasteurianum T Sarchami, G Munch, E Johnson, S Kießlich, L Rehmann Fermentation 2 (2), 13, 2016 | 63 | 2016 |
| Serum-free production of rVSV-ZEBOV in Vero cells: Microcarrier bioreactor versus scale-X™ hydro fixed-bed S Kiesslich, JPVC Losa, JF Gélinas, AA Kamen Journal of Biotechnology 310, 32-39, 2020 | 41 | 2020 |
| Production of rVSV-ZEBOV in serum-free suspension culture of HEK 293SF cells JF Gélinas, H Azizi, S Kiesslich, S Lanthier, J Perdersen, PS Chahal, ... Vaccine 37 (44), 6624-6632, 2019 | 32 | 2019 |
| Bioreactor production of rVSV‐based vectors in Vero cell suspension cultures S Kiesslich, GN Kim, CF Shen, CY Kang, AA Kamen Biotechnology and bioengineering 118 (7), 2649-2659, 2021 | 30 | 2021 |
| Consolidating biofuel platforms through the fermentative bioconversion of crude glycerol to butanol E Johnson, T Sarchami, S Kießlich, G Munch, L Rehmann World Journal of Microbiology and Biotechnology 32, 1-14, 2016 | 28 | 2016 |
| Haplotype-resolved de novo assembly of the Vero cell line genome MA Sène, S Kiesslich, H Djambazian, J Ragoussis, Y Xia, AA Kamen npj Vaccines 6 (1), 106, 2021 | 22 | 2021 |
| Process development for newcastle disease virus-vectored vaccines in serum-free vero cell suspension cultures JPC Fulber, O Farnós, S Kiesslich, Z Yang, S Dash, L Susta, SK Wootton, ... Vaccines 9 (11), 1335, 2021 | 20 | 2021 |
| Titration methods for rVSV-based vaccine manufacturing JF Gélinas, S Kiesslich, R Gilbert, AA Kamen MethodsX 7, 100806, 2020 | 17 | 2020 |
| Temporal characterization of protein production levels from baculovirus vectors coding for GFP and RFP genes under non‐conventional promoter control S George, AM Jauhar, J Mackenzie, S Kieβlich, MG Aucoin Biotechnology and bioengineering 112 (9), 1822-1831, 2015 | 16 | 2015 |
| Evaluation of novel HIV vaccine candidates using recombinant vesicular stomatitis virus vector produced in serum-free Vero cell cultures M Mangion, JF Gélinas, ABZ Gashti, H Azizi, S Kiesslich, N Nassoury, ... Vaccine 38 (50), 7949-7955, 2020 | 15 | 2020 |
| Pervaporative butanol removal from PBE fermentation broths for the bioconversion of glycerol by Clostridium pasteurianum S Kießlich, T Sarchami, G Munch, K Gao, L Rehmann, W Kujawski, ... Journal of Membrane Science 535, 79-88, 2017 | 15 | 2017 |
| Genomics of Vero Cells: Understanding this Cell Line and its Virus-Host Interactions for Improved Vaccine Production MA Sene McGill University (Canada), 2022 | | 2022 |
| Bioreactor production of rVSV-vectored vaccines in Vero cell suspension cultures S Kiesslich, G Kim, CF Shen, CY Kang, A Kamen Authorea Preprints, 2021 | | 2021 |
| Development of a Vero cell platform for rVSV vector production S Kiesslich McGill University (Canada), 2021 | | 2021 |
